Novartis AG is 28.4x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($282.64 B vs $9.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARWR | NVS |
|---|---|---|
| Market cap | $9.96 B | $282.64 B |
| US-listed rank | #941 | #47 |
| Revenue (latest FY) | $829.45M | - |
| Net income (latest FY) | -$1.63M | - |
| Net margin | -0.2% | - |
| SEC filings | 1,347 | 947 |
Novartis AG is 28.4x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($282.64 B vs $9.96 B).
Full pages: ARROWHEAD PHARMACEUTICALS, INC. and Novartis AG, or browse the full rankings.